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Abstract
Fragile X Syndrome (FXS) is characterized by mental impairment and autism in humans, and it often features hyperactivity
and repetitive behaviors. The mechanisms for the disease, however, remain poorly understood. Here we report that the
dfmr1 mutant in the Drosophila model of FXS grooms excessively, which may be regulated differentially by two signaling
pathways. Blocking metabotropic glutamate receptor signaling enhances grooming in dfmr1 mutant flies, whereas blocking
the vesicular monoamine transporter (VMAT) suppresses excessive grooming. dfmr1 mutant flies also exhibit elevated levels
of VMAT mRNA and protein. These results suggest that enhanced monoamine signaling correlates with repetitive behaviors
and hyperactivity associated with FXS.
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Introduction
Fragile X Syndrome (FXS) is the most common form of
inheritable mental impairment and the leading identified cause of
autism. It affects approximately 1/5000 males and roughly half as
many females [1]. FXS is caused by the loss of the fragile X mental
retardation protein (FMRP), largely due to transcriptional
silencing that results from a tri-nucleotide (CGG) repeat expansion
in the 59 untranslated region of the fragile X mental retardation 1
(FMR1) gene [2]. In addition to cognitive impairment, individuals
with FXS exhibit behavioral problems including hyperactivity,
attentional deficits, and impulsivity [3,4]. Autistic-like character-
istics, such as anxiety and stereotypic, repetitive behavior, are also
common features of FXS, and approximately 30% of patients
meet the diagnostic criteria for autism [5,6,7,8,9]. Studying the
role of FMRP in the nervous system is thus necessary to
understand the pathogenesis of both mental impairment and
autism and for developing new treatment strategies.
Mouse and fly models of FXS exhibit phenotypic defects
remarkably similar to the human disorder. Fmr1 knockout (KO)
mice, which lack expression of the mouse homolog of FMRP,
exhibit morphological abnormalities, learning and memory
defects, and behavioral problems including attentional dysfunc-
tion, impulsivity, anxiety, and excessive grooming [10,11,12,13].
The Drosophila gene dfmr1 codes for the protein dFMRP [14],
which contains the same functional domains as the mouse and
human homologues [15]. dfmr1 mutant flies exhibit defects in
neuronal morphology [15,16,17,18], physiology [17,19], circadian
rhythm [15,20,21,22], sleep [23], courtship [20], learning,
memory [24], and locomotion [17,19,25].
Although there is currently no effective treatment for FXS,
research in the past decade has significantly advanced the
understanding of the disorder. A major finding indicates that
synaptic plasticity is altered in KO mice due to hyperactive
signaling via the metabotropic glutamate receptor (mGluR) [26].
Further, reduction of mGluR expression in mutant mice, as well as
treatment with mGluR antagonists, remarkably improves a
number of phenotypes, including learning and memory
[27,28,29]. However, these measures do not correct maroorchid-
ism, indicating that enhanced mGluR signaling cannot account for
all FXS phenotypes [28]. This partial rescue in mice is consistent
with findings in Drosophila where reducing expression of DmGluR,
the Drosophila homolog of mGluR, rescues neuronal overbranching
[30] and physiological defects, but only partially improves synaptic
physiology [31]. Further, blocking DmGluR signaling with the
antagonist MPEP improves courtship, learning, memory, and
rescues morphology defects in dmfr1 mutant flies. MPEP, however,
fails to rescue abnormal circadian rhythm and sleep [32]. These
observations suggest that additional signaling pathways may be
altered in both mouse and fly models of FXS. Given recent
evidence suggesting that FMRP may regulate global translation,
rather than just a subset of translation important for mGluR
signaling, the inability of mGluR antagonists to correct all FXS
defects is not surprising [33,34]. While the evidence strongly
suggests that cognitive impairment in FXS results from aberrant
mGluR signaling, the neuronal mechanisms underlying hyperac-
tivity, impulsivity, and autistic-like behaviors remain poorly
understood.
Here we seek to determine other signaling pathways that may
be affected in the absence of dFMRP. We first identify the novel
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behavioral phenotype of excessive grooming in dfmr1 mutant flies,
which appears to reflect the hyperactive and autistic-like features
of FXS seen in mice and humans and adds another aspect of the
disorder that can be studied in Drosophila. We find that blocking
DmGluRs with MPEP does not reduce the excessive grooming in
dfmr1 mutant flies, supporting the idea that enhanced mGluR
signaling underlies only a subset of FXS phenotypes. Instead, our
results suggest that enhanced monoamine signaling correlates with
the excessive repetitive behavior in dfmr1 mutant flies.
Results
Wild-type dfmr1 transgene rescues aberrant climbing in
dfmr1 mutant flies
dfmr1 mutant flies are adult viable [17], but display a number of
locomotion defects, including abnormal crawling as larvae [25]
and impaired flight as adults [17]. We have shown that dfmr1
mutant flies fail to climb robustly and that climbing progressively
worsens with age [19]. To verify that abnormal climbing is directly
caused by the loss of dFMRP, we introduced a transgene
containing the wild-type dfmr1 gene under the control of the
endogenous promoter [20], into the dfmr1 mutant background. We
then investigated the climbing activity of genetically rescued
mutant flies (hereafter called control), dfmr1 mutant flies, and dfmr1
mutant flies containing a dfmr1 transgene with a frameshift (FS) in
the open reading frame of the genomic rescue fragment (see
Methods for further information on genotypes).
We monitored climbing performance at 5, 15, 25, and 35 days
post-eclosion. We first measured the time for the first fly in a
population of 10 flies to climb to a height of 17.5 cm (Movies S1
and S2). At 5 days old, the first fly in dfrm1 and FS populations
took, on average, 7.8 s and 7.5 s, respectively, to climb 17.5 cm,
significantly longer than the average of 3.9 s for control flies
(P,0.001; Fig. 1A). As the flies aged, the top performer in mutant
populations took progressively longer to reach the target height
(dfmr1 averaged 37 s and FS averaged 96 s at 35 days old; Fig. 1A).
In contrast, the climbing of top performers in control populations
changed little with age, averaging 5.7 s at 35 days old.
To better reflect the climbing activity of all flies in a population,
we counted how many flies reached 17.5 cm after 3 min and
determined the success rate (Fig. 1B). Similar to the data for the
top performers, 5 day-old mutant flies had a significantly lower
success rate than controls (P,0.001; Fig. 1B), and their success
rate declined with age. By 35 days, mutant groups approached a
0% success rate, a dramatic reduction from rates of 75% and 65%
for 5 day-old dfmr1 and FS flies, respectively (Fig. 1B). In contrast,
control flies exhibited a noticeable, but much smaller, decline in
success rate with age. We also measured the time for 50% of flies
to reach 17.5 cm, as well as the failure rates for the first fly, or 50%
of flies, in a population to complete the task successfully (Fig. S1).
For all of these parameters we observed similar age-dependent
declines in dfmr1 mutant flies. Hence, our climbing data
demonstrate an age-dependent decrease in climbing activity in
dfmr1 mutant flies, which is consistent with previous observations
[19]. Further, adding a copy of the wild-type dfmr1 gene to dfmr1
mutant flies rescues the abnormal climbing behavior, indicating
that this phenotype is caused specifically by the loss of dFMRP.
dfmr1 mutant flies groom excessively
While performing the climbing tests we observed that dfmr1
mutant flies frequently stopped climbing and began grooming
themselves. To study this behavior more directly we recorded the
activity of individual flies in a small observation chamber (see
Methods; Movies S3 and S4). At 5 days old, dfmr1 and FS flies
groomed, on average, for 19% and 22% of the 5 min observation
period, respectively (P,0.001; Fig. 2A). Control flies of the same
age groomed significantly less, averaging 7% (Fig. 2A). Similar to
the aberrant climbing, excessive grooming progressed with age in
mutant flies, reaching as high as 79% in 35 day-old FS flies.
Control flies, on average, spent 9% of the time grooming at 35
days, exhibiting little change in grooming activity with age.
In addition, the duration of individual grooming bouts increased
in dfmr1 mutant flies. At 5 days old, dfmr1 and FS flies had slightly
longer grooming bouts than control flies, but a significant difference
occurred only for FS flies (dfmr1: P.0.05, FS: P,0.05; Fig. 2B).
Similar to the overall grooming time in figure 2A, the average
grooming bout duration increased with age in mutant flies (Fig. 2B).
At 35 days, dfmr1 and FS flies groomed 35 s and 59 s per bout on
average, respectively, whereas control flies averaged 5 s per bout
(dfmr1: P,0.001, FS: P,0.01; Fig. 2B).
The mGluR antagonist MPEP partially rescues courtship
behavior, but enhances excessive grooming
To gain insight into the mechanisms underlying the excessive
grooming phenotype, we investigated the role of mGluR signaling.
Figure 1. Aberrant climbing is rescued by genomic expression of the dfrm1 gene. (A). The time for the first fly to climb 17.5 cm. dfmr1 and
FS (dfmr1 with a wild-type dfmr1 transgene that contains a frameshift mutation in the dfmr1 open reading frame) do not express functional dFMRP,
and show a progressive change in climbing behavior over the course of 35 days. The abnormal climbing is rescued by a transgene containing the
genomic wild-type dfmr1 locus (control). Data presented are the Mean +/- SEM (8 trials, total flies n = 80 for each genotype tested at each time point).
(B). Total percentage of flies that successfully reach the 17.5 cm mark within 3 min. For all data, *p,0.05, **p,0.01, and ***p,0.001.
doi:10.1371/journal.pone.0027100.g001
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We raised larvae and maintained adult flies on food containing
86 mM MPEP, a dosage previously shown to rescue courtship,
learning, memory, and neuronal morphology defects in dfmr1
mutant flies [32]. We first tested the effects of MPEP on naı¨ve
courtship activity to ensure the drug’s effectiveness. Courtship is an
extensively studied, stereotypic behavior in Drosophila in which the
male fly orients towards the female, tracks and follows her,
produces wing songs, and attempts to lick her genitalia [35]. If the
female is receptive, she then allows copulation. To quantify
courtship activity, we used the standard ’’Courtship Index’’ (CI),
defined as the percentage of time a male fly spends performing any
courtship behavior while in the presence of a female.
In agreement with the results of previous studies [20,32], we
observed reduced naı¨ve courtship in dfmr1 mutant flies. Both 5
day-old dfmr1 and FS flies had an average CI of approximately 6,
whereas control flies had a markedly higher CI of 25 (Fig. 3A).
Mutant flies treated with MPEP showed a partial, but significant,
improvement in naı¨ve courtship (P,0.01; Fig. 3A). Control flies
exhibited a small decrease in CI when treated with the drug, but
the change was not significant. Our results suggest that we
administered MPEP properly.
We proceeded to test the effect of MPEP on excessive grooming.
Surprisingly, we found that 15 day-old dfmr1 and FS flies treated
with MPEP showed a 2-fold and 1.5-fold increase in grooming
activity, respectively, compared to those not treated with the drug
(dfmr1: P,0.001, FS: P,0.05; Fig. 3B). In contrast, MPEP did not
appear to affect the grooming activity of control flies (Fig. 3B).
In addition to MPEP, lithium (LiCl, 5 mM) has also been shown
to rescue courtship, learning, and memory defects in dfmr1 mutant
flies [32]. In this study, 15 day-old dfmr1 and FS flies grown as
larvae and maintained as adults on food containing 5 mM lithium
showed no significant changes in grooming activity, nor did
control flies given the same treatment (Fig. 4). We also treated flies
with lithium only as adults (i.e. larvae were grown on food with no
Figure 2. dfmr1 mutant flies exhibit excessive grooming that increases with age. (A). At 5 days old, dfmr1 and FS flies groom significantly
more than control flies. Grooming increases with age in mutant flies; control flies show consistent levels of grooming at all ages tested. (B). The
average duration of grooming bouts in mutant flies follows a similar trend to the total time spent grooming (A). In contrast, control flies show little
change in the duration of grooming bouts from 5 to 35 days of age. Data are represented as the mean percentage of time single flies spend
grooming during a 5 min period (Mean +/- SEM; n = 10–15 flies for each genotype at each time point). For all data, *p,0.05, **p,0.01, and
***p,0.001.
doi:10.1371/journal.pone.0027100.g002
Figure 3. MPEP rescues courtship defects, but enhances excessive grooming in dfmr1mutant flies. (A). Treatment of dfmr1 mutant male
flies with MPEP improves courtship of naı¨ve females. Flies were grown as larvae and maintained as adults on either control food or food containing
86 mM MPEP. Data are presented as the mean courtship index (CI, +/- SEM) with sample sizes shown above each bar. dfmr1 and FS male flies treated
with MPEP engage in courtship activity with wild-type virgin females significantly more than when treated with no drug. Control flies court less when
treated with MPEP, but this difference is not significant. (B). 15 day-old dfmr1 and FS flies treated with 86 mM MPEP groom significantly more than
when treated with no drug. MPEP does not affect grooming activity in control flies. Data are presented as the mean percentage of time single flies
spend grooming during a 5 min period (Mean +/- SEM); sample sizes are displayed above each bar. For all data, *p,0.05 and ***p,0.001 (Two-tailed
students t-test).
doi:10.1371/journal.pone.0027100.g003
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drug), but found no difference in the drug’s effect (Fig. 4). We
therefore conclude that lithium, at a dosage that rescues other
dfmr1 behavioral defects, does not significantly affect the excessive
grooming in dfmr1 mutant flies.
Reserpine suppresses excessive grooming in dfmr1
mutant flies
As our results with MPEP suggested that excessive grooming in
dfmr1 mutant flies results from changes outside of mGluR
signaling, we searched for other disturbances caused by the loss
of dFMRP. FMRP has been shown to regulate dopamine signaling
in both mouse and fly models of FXS. In cultured neurons of Fmr1
KO mice, dopamine type 1 receptors are hyperphosphorylated
and defective in signaling [36]. In dfmr1 mutant flies, dopamine,
and to a lesser extent serotonin, is elevated in the brain [37].
Moreover, biogenic monoamines have been shown to play a
positive role in grooming in Drosophila. Application of dopamine,
octopamine, and serotonin to the ventral nerve cord of decapitated
flies stimulates grooming [38]. It has also been demonstrated that
overexpression of the Drosophila vesicular monoamine transporter
(dVMAT), which loads monoamines into synaptic vesicles,
increases grooming in flies [39]. Finally, blocking dVMAT with
the drug reserpine suppresses the elevated grooming activity in
flies that overexpress the transporter [39]. Hence, we next tested
the ability of reserpine to suppress excessive grooming in dfmr1
mutant flies to examine if enhanced monoamine signaling might
contribute to the behavior.
15 day-old mutant flies treated with varying concentrations of
reserpine (10, 15, 20, 30, and 50 mM) as both larvae and adults
exhibited a significant decrease in grooming at 50 mM (dfmr1:
P,0.01, FS: P,0.05), but not at the lower concentrations
(Fig. 5A). In contrast, control flies treated with reserpine as larvae
and adults showed significantly suppressed grooming at 10 mM
(P,0.01), 20 mM (P,0.001), and 30 mM (P,0.01) (Fig. 5A). To
determine if reserpine is effective post-developmentally, we treated
flies with the drug only after eclosion. Similar to figure 5A, 15 day-
old dfmr1 flies treated only as adults groomed significantly less at
50 mM (P,0.01), but not at lower concentrations (Fig. 5B). FS flies
treated with reserpine only as adults did not show a significant
difference in grooming at any concentration, but it is worth noting
that the reduction of grooming activity for 50 mM became
significant upon exclusion of an outlier in the sample (data not
shown). Like in figure 5A, post-developmental reserpine treatment
significantly reduced grooming in controls at lower dosages than in
mutants (Fig. 5B). Our results demonstrate that reserpine can
effectively suppress excessive grooming in dfmr1 mutant flies, is
effective when used only in adulthood, and that dfmr1 mutant flies
are less sensitive to reserpine than control flies.
dVMAT mRNA and protein levels are elevated in the
absence of dFMRP
As suppression of excessive grooming in mutant flies required a
higher dosage of reserpine, we hypothesized that dVMAT levels
could be increased in dfmr1 mutant flies. Although dFMRP is
primarily known to regulate translation, it has also been shown to
influence transcript expression [40,41,42,43]. To determine if
dVMAT mRNA levels are affected by the loss of dFMRP, we used
quantitative real-time polymerase chain reaction (qPCR) to
quantify dVMAT transcript levels in dfmr1 mutant flies. At 5 days
of age, dfmr1 mutant flies showed a 29% increase in dVMAT
mRNA compared to control flies, but the change was not
significant (P.0.05; Fig. 6A). At 25 days of age, we detected a 41%
increase in dVMAT transcript levels in mutant flies compared to
control flies. This increase was significant for dfmr1 flies, but not for
FS flies (dfmr1: P,0.05, FS: P.0.05; Fig. 6B). Thus, dVMAT
transcript levels increased in dfmr1 mutant flies over time, up to the
age we tested.
We next examined the effect of the absence of dFMRP on
dVMAT protein levels. Consistent with the increase in mRNA, we
detected a 77% and 35% elevation of dVMAT protein levels in 5
day-old dfmr1 and FS fly heads, respectively, compared to 5 day-
old control fly heads. This represents a significant increase in
dVMAT protein levels for dfmr1 but not for FS flies (dfmr1:
P,0.05; FS: P.0.05; Fig. 6C). We also detected elevated dVMAT
protein levels at 25 days in dfmr1 (52%) and FS (74%) flies, but
neither increase was statistically significant compared to control
flies at both 5 and 25 days (Fig. 6D). Hence, our results show a
trend that dVMAT transcript and protein levels are both
upregulated in dfmr1 mutant flies, and under certain conditions
the increases reach statistically significant levels.
Discussion
There are four major findings from this study: 1) age-dependent
abnormal climbing in dfmr1 mutant flies can be genetically
rescued, 2) excessive grooming is identified as a new behavioral
defect in dfmr1 mutant flies, 3) excessive grooming can be
suppressed by reserpine, and 4) dVMAT mRNA and protein levels
are increased in the absence of dFMRP.
In a previous study we revealed abnormal climbing activity in
dfmr1 mutant flies that progresses with age. Our results in this
study confirm this finding, and additionally show that introducing
a wild-type dfmr1 transgene into the dfmr1 mutant background
restores normal climbing behavior. Further, a frameshift mutation
in the open reading frame of the transgene abolishes the rescue of
climbing behavior. These results demonstrate that the abnormal
climbing in dfmr1 mutant flies is directly caused by the loss of
dFMRP.
In this study we have also identified excessive grooming as an
important and novel behavioral defect in the fly model of FXS.
Our results show that dfmr1 mutant flies groom significantly more
than control flies, and that mutant flies also have significantly
longer grooming bouts. Further, this excessive grooming intensifies
Figure 4. Lithium does not significantly affect grooming in
dfmr1 mutant flies. Grooming activity of 15 day-old flies grown as
larvae and maintained as adults, or only maintained as adults on food
containing 5 mM LiCl. Data are presented as the mean percentage of
time single flies spend grooming during a 5 min period (Mean +/- SEM);
sample sizes are displayed above each bar. For all genotypes, LiCl
causes no significant change in grooming activity (Kruskal-Wallis one-
way ANOVA with Dunn’s post-hoc comparison).
doi:10.1371/journal.pone.0027100.g004
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with age in dfmr1 mutant flies, whereas control flies show
essentially no change in grooming activity over time. A wild-type
copy of the dfmr1 gene can rescue the excessive grooming defect in
dfmr1 mutant flies. It is worth noting that FS mutants show more
dramatic climbing and grooming defects compared to dfmr1
mutants. We do not know the exact underlying cause, but it may
be due to the presence of either mRNA or a truncated peptide
produced from the FS rescue fragment, having gain of function
effects.
In video recordings, control flies mostly walk around the
observation chamber and groom occasionally, but rarely stand
motionless. In contrast, the mutant fly spends more time
Figure 5. Dosage effects of reserpine on grooming. (A). Grooming activity of 15 day-old flies grown as larvae and maintained as adults on food
containing no drug, 10, 30, or 50 mM reserpine (15 and 20 mM are omitted from figure). Reserpine suppresses grooming in dfmr1 and FS flies, but only
at 50 mM; control flies show significantly reduced grooming at the lowest concentration, 10 mM. (B). 15 day-old flies treated with reserpine only as
adults (i.e. larvae were grown on control food), show a similar response. Suppressed grooming in mutant flies is only significant at 50 mM. In contrast,
reserpine significantly decreases grooming activity in control flies at 15 mM. Data are presented as the mean percentage of time single flies spent
grooming during a 5 min period (Mean +/- SEM); sample sizes are displayed above each bar. For all data, *p,0.05 and ***p,0.001 (Kruskal-Wallis
one-way ANOVA with Dunn’s post-hoc comparison).
doi:10.1371/journal.pone.0027100.g005
Figure 6. dVMAT transcript and protein levels are upregulated in dfmr1mutant flies. Quantitative real-time PCR experiments indicate that
dVMAT mRNA levels are increased in 5 day-old dfmr1 mutant flies (A) and in 25 day-old dfmr1 mutant flies (B) relative to control flies. Western blot
analyses indicate that dfmr1 mutant flies also have increased levels of dVMAT protein at both (C) 5 days and (D) 25 days of age. (E) Representative
blot showing increased dVMAT protein levels in dfmr1 and FS flies compared to control flies. Real-time PCR data are presented as the average of three
biological replicates. Western blot data are shown as the average of three independent trials. *p,0.05 (One-way ANOVA with Dunnett’s post-hoc
comparison).
doi:10.1371/journal.pone.0027100.g006
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grooming. It is possible that grooming is a default activity that
occurs whenever a fly is not walking. If this is the case, excessive
grooming in dfmr1 mutant flies could result indirectly from
problems in walking. This explanation would be consistent with
our observation that dfmr1 mutant flies exhibit postural problems
and uncoordinated movement. However, the dfmr1 flies are
capable of climbing after a brief period of mechanical disturbance
(i.e., knocking them down in the graduated cylinder), albeit at a
slower speed compared to control flies. Further, reserpine
suppresses grooming in dfmr1 mutant flies without improving
walking (data not shown). These observations suggest that
grooming is not simply a default behavior in the absence of
walking and that dfmr1 mutations specifically cause excessive
grooming. Notably, Fmr1 KO mice have also been reported to
exhibit excessive grooming when presented with social stimuli
[11,13]. A study of self-injurious behavior in FXS patients
reported a prevalence of harmful rubs and scratches [44]. Hence,
heightened repetitive activity such as grooming is a common
behavioral defect in FXS.
Although reducing mGluR signaling has been shown to rescue
learning and memory defects in both mouse and fly FXS models,
we find that the mGluR antagonist MPEP enhances excessive
grooming in dfmr1 mutant flies. This is not completely surprising,
as the absence of dFMRP likely alters numerous signaling
pathways and developmental processes of the nervous system.
MPEP also fails to rescue abnormal sleep [23] and circadian
rhythm [32] in dfmr1 mutant flies, which may impact locomotor
activity like grooming. It is worth noting that dfmr1 mutant flies did
not groom more when treated with LiCl, suggesting that mGluR
antagonists and LiCl may have different neuronal targets. An
interesting question that arises from these results is whether an
mGluR agonist might suppress grooming in dfmr1 mutant flies.
Previous results have shown that glutamate at concentrations as
low as 5 mM is toxic to dfmr1 mutant flies and significantly affects
various behaviors in the fly [45]. This makes it difficult to assess
the potential benefit of mGluR agonists on grooming.
Previous work shows that dopamine plays a role in FXS in both
mice [36] and Drosophila [37], and that biogenic monoamines
stimulate fly grooming [38,39]. In our studies, blocking dVMAT
with reserpine suppresses excessive grooming in dfmr1 mutant flies,
but only significantly at 50 mM. Control flies groom significantly
less when treated with just 10 mM. These results indicate that dfmr1
mutant flies are less sensitive to reserpine’s effect on grooming.
However, we cannot exclude the possibility that reserpine has
additional targets and therefore generally sedates the fly. Both
suppression of dVMAT as well as a non-specific target could slow
down most motor activities including grooming. Alternatively, it is
possible that basal monoamine activity is required for grooming,
and therefore shutting down monoamine signaling may block the
behavior.
In our study, we find elevated levels of dVMAT transcript and
protein in dfmr1 mutant flies. Although these increases are not
statistically significant in some instances, they are consistent in
both mutant lines. However, it is not clear from our results how
the loss of dFMRP leads to increased dVMAT expression. The
transcription of dVMAT may be directly increased. Alternatively,
degradation of dVMAT mRNA may decrease in the absence of
dFMRP, a distinct possibility as FMRP has been previously
indicated to regulate mRNA stability [46]. How dFMRP regulates
dVMAT protein levels is also unclear. Elevated dVMAT protein
levels may occur exclusively because of increased transcript levels,
but could also result from increased translation or reduced
degradation of the protein. Nonetheless, our observations are in
agreement with the known function of FMRP as a regulator of
transcription and translation [40,42,47].
Many factors may contribute to the excessive grooming in dfmr1
mutant flies, and our data do not resolve whether upregulation of
dVMAT directly influences this behavior. Overexpression of
dVMAT stimulates grooming in flies [39], and dopamine levels
are increased in dfmr1 mutant brains [37]. Monoamines could
directly or indirectly modulate multiple downstream signaling
pathways involved in grooming. The hyposensitivity to reserpine
seems to suggest that a greater number of dVMATs are present on
mutant synaptic vesicles, as a higher concentration of the drug is
required to reduce grooming. We note that overexpression of
dVMAT in serotonergic and dopaminergic neurons leads to
hypersensitivity to reserpine on grooming [39]. One likely
explanation of these differences is that dfmr1 mutations affect not
only monoamine cells but also other cells such as neurons in the
mushroom bodies and neurons postsynaptic to monoamine cells.
We are also are aware that dopamine signaling is reduced in the
forebrain of Fmr1 KO mice [36]. Thus, while plausible given the
effect of reserpine, we cannot establish a clear causal relationship
between excessive grooming and dVMAT expression levels.
Understanding how FMRP functions in development and aging
will be crucial for effective treatment of FXS [48,49]. Studies in
mouse and Drosophila indicate that FMRP is temporally regulated
and that treatment requires proper timing [50,51,52,53,54]. Our
results add to the growing evidence of the importance of FMRP in
age-related processes, and also demonstrate that hyperactivity and
repetitive behavior increase with age in the Drosophila model.
Interestingly, the severity of autistic behavior and anxiety has been
found to increase with age in studies of FXS patients [55,56]. Our
results indicating that reserpine is effective in adult dfmr1 mutant
flies could help develop or improve treatment, as they suggest that
hyperactive and repetitive behavior in older patients is potentially
reversible.
Although we believe excessive grooming in dfmr1 mutant flies is
a model of an impulsive and repetitive behavior, animal models
can never completely recapitulate human disorders. The mecha-
nisms underlying repetitive behaviors in FXS patients are likely
much more complex. Nonetheless, we demonstrate a correlation
between monoamine signaling and the excessive grooming
phenotype in dfmr1 mutant flies and that VMAT is a protein that
merits further study in FXS. Importantly, our study provides
potentially useful information for improving the pharmaceutical
treatment of FXS symptoms in human patients.
Materials and Methods
Fly stocks, Genetics, and Pharmacology
Flies were grown on a standard cornmeal-agar medium under a
12 h/12 h light/dark cycle. fragile X (dfmr1) mutant flies were
generated by crossing w; dfmr183M/TM6B, Tb with w; dfmr13/
TM6C, Sb flies and selecting w; dfmr183M/dfmr13 flies from the
progeny [17,20]. Control flies, which contain a transgene
encoding the wild-type dfmr1 gene in the dfmr1 mutant back-
ground, were generated by crossing w; dfmr183M/TM6B, Tb with
w; wild-type rescue (WT)/+; dfmr13/TM6C, Sb flies [20]. FS flies,
which carry a frameshift in the open reading frame of the
transgenic rescue fragment were generated by crossing w;
dfmr183M/TM6B, Tb with w; frameshift rescue (FS)/+; dfmr13/
TM6C, Sb flies [20]. For grooming assays, 1–3 day-old adult male
flies were collected following brief anesthetization with CO2. Flies
were stored in fresh food vials with 10–13 flies per vial (climbing)
or 2–8 flies per vial (grooming). For MPEP and LiCl administra-
tion, an aqueous stock solution was mixed into recently cooked
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standard food after the food had cooled. As reserpine is insoluble
in water, a stock solution in 1 M acetic acid was mixed into molten
food in a 1:9 ratio [39]. For control experiments, flies were raised
on food containing the same amount of each vehicle (water or
acetic acid). Flies were transferred to new food vials every 4–6
days.
Behavioral Assays
Climbing. For climbing trials, 10 male flies were transferred
to a 250 mL glass graduated cylinder, which was sealed with
parafilm to prevent escape. Next, the flies were knocked down to
the bottom; and care was taken to use similar force for all trials.
Measurements were taken for the (1) time for the first fly to cross
the 150 mL line (17.5 cm from the bottom); (2) percentage of trials
when a first fly did not cross the 17.5 cm line within 3 min; (3)
time for 50% of the population to cross the 17.5 cm line; (4)
percentage of trials when 50% of the population did not cross the
17.5 cm line within 3 min; and (5) the percentage of flies that
crossed the 17.5 cm line within 3 min. Four trials were performed
for each population and their average was taken for a sample
value. A total of 8 samples were taken for each genotype. For data
analysis we excluded events for (1) in which no fly, and for (3) in
which 50% of a population, did not reach 17.5 cm within 3 min.
Experiments were performed between 5–7 pm to minimize
potential effects of circadian oscillation.
Courtship. Virgin male flies collected within 4 hours of
eclosion were stored in individual food vials. Virgin wild-type (CS,
Canton S) female flies, collected on the same day as the virgin
males, were kept in groups of 10–20 per food vial. All courtship
assays were performed with 5 day-old male and female flies
between 3–6 pm. Male flies were first aspirated into an
observation chamber of about 0.4 cm3, and after 1 min of
acclimation, a virgin wild-type female was aspirated into the
chamber and behavior was then monitored for 10 min. The
courtship index (CI) was scored as the percentage of time that a
male fly spent engaged in courtship activity while paired with a
female [32,57]. Courtship behavior was recorded on video and
analyzed later using the iVideo program for Macintosh.
Grooming. Single male flies were aspirated into a 0.4 cm3
observation chamber, allowed to acclimate for 1 min, and then
recorded for a 5 min observation period. Data were collected for
(1) the percentage of time the fly spent grooming and (2) the
duration of individual grooming bouts. Grooming bouts were
recorded as ending when a fly either stopped grooming and
remained motionless for 2 s, or stopped grooming and walked at
least 4 steps. Grooming experiments were performed between 3–
6 pm and were recorded and analyzed using video software.
Quantitative Real-time PCR
Flies were collected within 24 hours of eclosion, aged for 5 days
or 25 days, and frozen in liquid nitrogen between 3–6 pm.
Samples were stored at 280uC. Three biological replicates were
used for each genotype at each age. RNA was extracted from 40
flies with TRIzol (Invitrogen) and purified using a Qiagen RNeasy
Mini Kit (Qiagen) with on-column DNase I (Qiagen) treatment.
RNA yield and purity was checked with a NanoDrop 2000
Specrophotometer (Thermo Scientific). To generate cDNA,
0.4 mg of RNA was used with a SuperScript III Reverse
Transcriptase First-Strand Synthesis Kit (Invitrogen). Real-time
PCR was performed using a Maxima SYBR Green/ROX qPCR
Master Mix (Fermentas). Analyses were performed using an
Applied Biosystems 7500 Real-time PCR System. Relative
expression levels were determined with the 22ddCt method [58],
using rp49 as a reference gene. qPCR primer sequences for
dVMAT were:
59-AAAATTGGACGATGGTTTGC-39 (forward) and
59-ATTCGGGATGATCAGGTGAG-39 (reverse);
primer sequences for rp49 were:
59-CGGATCGATATGCTAAGCTGT-39 (forward) and
59-GCGCTTGTTCGATCCGTA-39 (reverse).
Western blots
Flies were collected within 24 hours of eclosion, aged for 5 days
or 25 days, and frozen in liquid nitrogen between 3–6 pm.
Samples were stored at 280uC. An equal number of fly heads
were isolated for each experiment (15–20 total/condition),
homogenized in Buffer A (150 mM NaCl, 10 mM HEPES,
pH 7.4, 1 mM EGTA, 0.1 mM MgCl2, 2 mM PMSF, and
protease inhibitor cocktail) (Roche, Indianapolis, IN) using a
plastic pestle. Protein lysates were cleared by centrifugation at
22,000 x g for 20 min. Total protein concentration was measured
by a BCA Assay (Thermo Scientific, Rockford, IL), diluted with 2
x SDS Sample Buffer, boiled for 5 min, and equal concentrations
of protein were separated on a 10% SDS-PAGE gel for each
condition. Following transfer to nitrocellulose, the membranes
were incubated overnight at 4uC at 1:4000 in rabbit anti-dVMAT
[59], washed in 0.5% TBS-Tween, and incubated for 1 h at
1:4000 in HRP-conjugated rabbit secondary antibody. Protein was
detected using the ECL method, normalized to tubulin (Sigma, St.
Louis, MO), and quantified using Image J (NIH).
Statistical Analysis
Most statistical analyses were performed using GraphPad Prism
4. ANOVA with a Dunnett’s multiple comparison test was used
for statistical analysis, unless noted otherwise. For data that were
not normally distributed, and for which transformation could not
resolve this issue, a non-parametric test was used (Kruskal-Wallis
one-way ANOVA with a Dunn’s post-hoc test). All data are shown
as mean +/- SEM. *p,0.05, **p,0.01, and ***p,0.001 are
considered statistically significant.
Supporting Information
Figure S1 Additional measurements of climbing behav-
ior in dfmr1 mutant flies. (A). Time for 50% of a population
to climb 17.5 cm. Control flies contain a wild-type dfmr1 transgene
under endogenous regulation in the dfmr1 mutant background.
dfmr1 and FS (dfmr1 mutants that contain a wild-type dfmr1
transgene that has a frameshift mutation in the dfmr1 open reading
frame) do not express functional dFMRP. By 35 days all dfmr1 and
FS populations failed to have 50% reach 17.5 cm within 3 min.
Data presented are the average of Mean +/- SEM (8 trials, total
flies n = 80 for each genotype tested at each time point). (B).
Percentage of failed attempts for populations to have a first fly
reaching the 17.5 cm line. (C). Percentage of failed attempts for
populations to have at least 50% of flies climb 17.5 cm. For all
data, *p,0.05, **p,0.01, and ***p,0.001.
(TIF)
Movie S1 Sample video of control flies climbing. This video
illustrates how climbing experiments were conducted. Ten control
flies at 15 day-old were gently knocked to the bottom of a
graduated cylinder and then observed to climb to the top.
(MOV)
Movie S2 Sample video of the dfmr1 mutant flies climbing. Ten
dfmr1 mutant flies at 15 day-old were gently knocked to the bottom
of a graduated cylinder. The flies then begin climbing, but some
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stop after a short period of time. Later analysis showed that these
flies stopped to groom themselves.
(MOV)
Movie S3 Sample video of dfmr1 mutant grooming activity. A 15
day-old dfmr1 mutant fly initially explores the environment for
10 s, but then begins grooming excessively.
(MOV)
Movie S4 Sample video of grooming activity in a control fly. A
15 day-old control fly explores the environment, stopping only
once to groom for 3 s.
(MOV)
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